{"id":29099,"date":"2012-05-06T19:51:21","date_gmt":"2012-05-06T23:51:21","guid":{"rendered":"http:\/\/countingpips.com\/fx\/?p=29099"},"modified":"2012-05-06T19:51:21","modified_gmt":"2012-05-06T23:51:21","slug":"warner-chilcott-reports-mixed-results-cuts-guidance-wcrx","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/fx\/2012\/05\/06\/warner-chilcott-reports-mixed-results-cuts-guidance-wcrx\/","title":{"rendered":"Warner Chilcott Reports Mixed Results, Cuts Guidance (WCRX)"},"content":{"rendered":"<p><div id=\"grabDiv1767162\"><object id=\"GrabPlayer1767162\" width=\"542\" height=\"304\" type=\"application\/x-shockwave-flash\" align=\"middle\" data=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v08cdc764cfdef3b566fa2118a764ca3f150bed83&#038;tgt=grabnetworks\"><param name=\"quality\" value=\"high\"\/><param name=\"allowScriptAccess\" value=\"always\"\/><param name=\"allowFullScreen\" value=\"true\"\/><param name=\"menu\" value=\"false\"\/><param name=\"wmode\" value=\"transparent\"\/><param name=\"movie\" value=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v08cdc764cfdef3b566fa2118a764ca3f150bed83&#038;tgt=grabnetworks\"\/><\/object><\/p>\n<div id=\"overlay-adzone\" style=\"overflow:hidden; position:relative\"><\/div>\n<\/div>\n<p>Warner Chilcott (NASDAQ:WCRX) reported Q1 EPS of $1.16, topping estimates of $0.17. Revenues in the quarter fell 9.5% year-over-year to $685 million, missing estimates by $37 million. Warner Chilcott sees FY 2012 adjusted CNI per share $3.30-$3.40, vs. its prior guidance of $3.60-$3.70. The company sees revenues of $2.4 billion &#8211; $2.5 billion, vs. its prior guidance of $2.5 billion &#8211; $2.6 billion. SmarTrend is bullish on shares of Warner Chilcott and our subscribers were alerted to buy on April 25, 2012 at $17.30. The stock has risen 25.1% since the alert was issued. Warner Chilcott PLC is a pharmaceutical company. The Company is focused on marketing, selling, developing and manufacturing branded prescription pharmaceutical products in women&#8217;s healthcare and dermatology in the United States.<\/p>\n<p><img src='http:\/\/cache.thenewsroom.com\/financial_news_network\/2012\/05\/06\/1_n7m0wvbo_thumb.jpg' \/><\/p>\n<p><!--post_img[http:\/\/cache.thenewsroom.com\/financial_news_network\/2012\/05\/06\/1_n7m0wvbo_preview.jpg]--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Warner Chilcott (NASDAQ:WCRX) reported Q1 EPS of $1.16, topping estimates of $0.17. Revenues in the quarter fell 9.5% year-over-year to $685 million, missing estimates by $37 million. Warner Chilcott sees FY 2012 adjusted CNI per share $3.30-$3.40, vs. its prior guidance of $3.60-$3.70. The company sees revenues of $2.4 billion &#8211; $2.5 billion, vs. its &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.investmacro.com\/fx\/2012\/05\/06\/warner-chilcott-reports-mixed-results-cuts-guidance-wcrx\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Warner Chilcott Reports Mixed Results, Cuts Guidance (WCRX)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-29099","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/29099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/comments?post=29099"}],"version-history":[{"count":0,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/29099\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/media?parent=29099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/categories?post=29099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/tags?post=29099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}